South Africa’s health regulator authorizes Sinopharm COVID-19 vaccine
Category: #headlines |   By Pankaj Singh |   Date: 2022-02-08

South Africa’s health regulator authorizes Sinopharm COVID-19 vaccine

The South African health regulator has reportedly approved Sinopharm, a COVID-19 vaccination from China. A senior health executive claimed that the government doesn’t plan to acquire vaccine doses for now.

South Africa, which has been hit the hardest by the COVID-19 pandemic in terms of infections and deaths, has deployed the Pfizer-BioNTech and Johnson & Johnson (J&J) vaccines in its vaccination campaign after negotiating supply agreements with the two American pharmaceutical corporations.

However, due to an overstock of vaccines, the government postponed certain vaccination distribution programs scheduled late last year, as uncertainty slowed the uptake.

According to SAHPRA, the vaccine was approved on the basis of accepted safety, quality, and efficacy evidence given by MC Pharma, which is a local regulatory pharmaceutical business that has collaborated with Sinopharm.

The vaccine has been approved for those aged 18 and above, subject to certain restrictions, including that it has to be given in accordance with the national vaccination schedule and that periodic safety updates are provided.

Nicholas Crisp, Deputy Director-General of the health department stated that they would not be purchasing the vaccines as of now, since plenty of stock is available in stores.

For those unaware, the World Health Organization (WHO) approved a Sinopharm COVID-19 vaccine for emergency use in May. Clinical trials revealed that it was less effective against symptomatic disease than the Pfizer-developed injection.

In December, the WHO urged that persons who had received an inactivated COVID-19 vaccination, made by Sinopharm, Sinovac Biotech, and Bharat Biotech in India, have a booster dose to counter fading immunity.

Inactivated vaccinations work by using chemicals, heat, or radiation to inactivate or destroy the SARS-CoV-2 virus. It is worth mentioning here that around 42% of South Africa's adult population which is around 40 million people has been fully vaccinated so far.

 

Source Credit:

https://www.msn.com/en-us/news/other/south-african-regulator-approves-sinopharm-covid-vaccine/ar-AATy3nm?ocid=bingcovid

  • shareShare
  • Twitter
  • Facebook
  • LinkedIn


About Author

Pankaj Singh     Twitter

Pankaj Singh

With a commendable experience of content creation under his belt, Pankaj Singh, a qualified Post Graduate in Management, boasts of having worked as a freelance writer and an insurance underwriter. Additionally, Pankaj has also enriched his qualification portfolio with Read more...

More News By Pankaj Singh

Shaurrya Teleservices & Airwaive team up to expand 5G network in India

Shaurrya Teleservices & Airwaive team up to expand 5G network in India

By Pankaj Singh

Airwaive and Shaurrya Teleservices (STS) has reportedly announced an international strategic collaboration to jointly build 5G wireless network service in India, assisting telecom providers in advancing 5G technology throughout the nation. Notably...

Valneva looking to capitalize on growing prevalence of Lyme disease

Valneva looking to capitalize on growing prevalence of Lyme disease

By Pankaj Singh

French drugmaker Valneva SE is now reportedly betting on its vaccine VLA15 for treating climate change-induced Lyme disease, as it looks to capitalize on growing prevalence of tick-borne illnesses following the disappointing sales of its COVID-19 vac...

Reliance Jio becomes the largest buyer of India’s USD 19 Bn 5G sale

Reliance Jio becomes the largest buyer of India’s USD 19 Bn 5G sale

By Pankaj Singh

Reliance Jio Infocomm Ltd., owned by billionaire industrialist Mukesh Ambani, was found to be the most aggressive participant in the government-backed 5G auction in India where several telecom behemoths agreed to invest at least USD 19 billion. Jio w...